AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,933,000 | -42.2% | 843,940 | -27.5% | 1.12% | -28.7% |
| Q2 2020 | $17,186,000 | +9.3% | 1,164,343 | 0.0% | 1.56% | -45.7% |
| Q1 2020 | $15,719,000 | -46.9% | 1,164,343 | -4.9% | 2.88% | -35.5% |
| Q4 2019 | $29,604,000 | +52.4% | 1,224,825 | +21.2% | 4.46% | +94.4% |
| Q3 2019 | $19,422,000 | +414.6% | 1,010,488 | +910.5% | 2.29% | +1226.0% |
| Q3 2016 | $3,774,000 | – | 100,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |